Nuwellis, Inc. (NUWE) stock

NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/3082% below fair value

$4.90−0.13 (-2.58%)

Close on Nov 13, 2026Market cap $2.65MP/E –Yield –

Nuwellis EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Nuwellis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NUWE.

Revenue growth10.3% · median 28.5%

Gross margin70.8% · median 55.6%

Operating margin-135.8% · median -186.2%

Net margin-152.8% · median -185.2%

Advertisement
300 × 250

See a number that looks wrong?